ALPS ETF TR - MED BREAKTHGH (SBIO)

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / MED BREAKTHGH
Total 13F shares
1,418,814
Share change
-19,092
Total reported value
$47,816,949
Put/Call ratio
0%
Price per share
$33.58
Number of holders
37
Value change
-$668,734
Number of buys
12
Number of sells
17

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q2 2024

As of 30 Jun 2024, ALPS ETF TR - MED BREAKTHGH (SBIO) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,418,814 shares. The largest 10 holders included DAVENPORT & Co LLC, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, NTV Asset Management LLC, LPL Financial LLC, Phoenix Wealth Advisors, GRIFFIN ASSET MANAGEMENT, INC., and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 37 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.